Trial · NCT04032080
Adverse events72
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 72
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Musculoskeletal and connective tissue disorders | LY3023414 + Prexasertib | 2 | 10 | 2 |
| other | Abnormal HBA1C | Investigations | LY3023414 + Prexasertib | 2 | 10 | 2 |
| other | Abnormal LVEF | Cardiac disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Axillary Cellulitis | Infections and infestations | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Axillary Pain | Musculoskeletal and connective tissue disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Axillary Swelling | Blood and lymphatic system disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | LY3023414 + Prexasertib | 3 | 10 | 3 |
| other | Chest Wall Pain | Musculoskeletal and connective tissue disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Bronchitis | Infections and infestations | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Chest Pressure | General disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Chills | General disorders | LY3023414 + Prexasertib | 2 | 10 | 3 |
| other | Cognitive Changes | Nervous system disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Constipation | Gastrointestinal disorders | LY3023414 + Prexasertib | 5 | 10 | 5 |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | LY3023414 + Prexasertib | 2 | 10 | 2 |
| other | Diarrhea | Gastrointestinal disorders | LY3023414 + Prexasertib | 7 | 10 | 15 |
| other | Dry Mouth | General disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Dysgeusia | Nervous system disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Dysphagia | Nervous system disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
| other | Dysuria | Renal and urinary disorders | LY3023414 + Prexasertib | 2 | 10 | 3 |
| other | Encephalopathy | Nervous system disorders | LY3023414 + Prexasertib | 1 | 10 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04032080/events